[1] Langedijk JAGM, Beuers UH, Oude ERPJ.
Cholestasis-associated pruritus and its pruritogens[J]. Front
Med (Lausanne), 2021, 8: 639674. DOI: 10.3389/
fmed.2021.639674.
[2] Galoosian A, Hanlon C, Zhang J, et al. Clinical updates in
primary biliary cholangitis: trends, epidemiology, diagnostics,
and new therapeutic approaches[J]. J Clin Transl Hepatol,
2020,8:49-60.
[3] Gossard AA, Keith DL. Current and promising therapy for
primary biliary cholangitis[J].Expert Opin Pharmacother,2019,
20(9):1161-1167.DOI: 10.1080/14656566.2019.1601701.
[4] 中华医学会肝病学分会. 原发性胆汁性胆管炎的诊断和治
疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38(1): 35-41. DOI:
10.3760/cma.j.cn112138-20211112-00794.
[5] Lindor KD, Kowdley KV, Luketic VAC, et al. High-dose
ursodeoxycholic acid for the treatment of primary sclerosing
cholangitis[J].Hepatology,2009,50(3):808-814.DOI: 10.1002/
hep.23082.
[6] 耿文静,刘晖,范春蕾,等.药物性肝内胆管消失综合征的临床
特征与转归[J].首都医科大学学报,2018,39(5):675-679.
[7] de Jong IEM, Overi D, Carpino G, et al. Persistent biliary
hypoxia and lack of regeneration are key mechanisms in the
pathogenesis of posttransplant nonanastomotic strictures[J].
Hepatology,2022,75(4): 814-830. DOI: 10.1002/hep.32166.
[8] Vries Y, von Meijenfeldt FA, Porte RJ. Post-transplant
cholangiopathy: classification, pathogenesis, and preventive
strategies[J]. Biochim Biophys Acta Mol Basis Dis, 2018,
1864(4 Pt B):1507-1515. DOI: 10.1016/j.bbadis.2017.06.013.
[9] Sticova E, Jirsa M. ABCB4 disease: many faces of one gene
deficiency[J].Ann Hepatol, 2020,19(2):126-133.DOI:10.1016/
j.aohep.2019.09.010.
[10] Jankowska I,Pawłowska J,Szymczak M,et al.A report of 2
infant siblings with progressive intrahepatic familial
cholestasis type 1 and a novel homozygous mutation in the
ATP8B1 gene treated with partial external biliary diversion
and liver transplant[J].Am J Case Rep,2021,22:e932374.DOI:
10.12659/AJCR.932374.
[11] Odevixibat (Bylvay) for progressive familial intrahepatic
cholestasis-associated pruritus[J].Med Lett Drugs Ther,2022,
64(1644):28-29.
[12] Valamparampil JJ, Girish LG. Cystic fibrosis associated liver
disease in children [J]. World J Hepatol, 2021, 13(11):
1727-1742. DOI: 10.4254/wjh.v13.i11.1727.
[13] Aabakken L,Karlsen TH,Albert J,et al.Role of endoscopy in
primary sclerosing cholangitis: European Society of
Gastrointestinal Endoscopy (ESGE) and European Association
for the Study of the Liver (EASL) Clinical Guideline[J].
Endoscopy, 2017, 49(6): 588-608. DOI: 10.1055/
s-0043-107029.
[14] Fung BM,Tabibian JH.Biliary endoscopy in the management
of primary sclerosing cholangitis and its complications[J].
Liver Res,3(2):106-117. DOI:10.1016/j.livres.2019.03.004.
[15] Subhash A,Buxbaum JL,Tabibian JH.Peroral cholangioscopy:
update on the state-of-the-art[J].World J Gastrointest Endos,
14(2):63-76. DOI: 10.4253/wjge.v14.i2.63.
[16] Karagyozov P, Boeva I, Tishkov I. Role of digital
single-operator cholangioscopy in the diagnosis and treatment
of biliary disorders[J]. World J Gastrointest Endosc, 2019,
11(1):31-40. DOI: 10.4253/wjge.v11.i1.31.
[17] Itoi T,Kamisawa T,Igarashi Y,et al.The role of peroral video
cholangioscopy in patients with IgG4-related sclerosing
cholangitis[J]. J Gastroenterol, 2013, 48(4): 504-514. DOI:
10.1007/s00535-012-0652-6.
[18] Subhash A, Abadir A, Iskander JM, et al. Applications,
limitations, and expansion of cholangioscopy in clinical
practice[J].Gastroenterol Hepatol,17(3):110-120.
[19] Siiki A, Rinta-Kiikka I, Koivisto T, et al. Spyglass
single-operator peroral cholangioscopy seems promising in
the evaluation of primary sclerosing cholangitis-related biliary
strictures[J]. Scand J Gastroenterol, 2014, 49(11): 1385-1390.
DOI: 10.3109/00365521.2014.940376.
[20] Arnelo U,von Seth E,Bergquist A.Prospective evaluation of
the clinical utility of single-operator peroral cholangioscopy in
patients with primary sclerosing cholangitis[J]. Endoscopy,
2015,47(8):696-702. DOI: 10.1055/s-0034-1391845.
[21] Njei B,McCarty TR,Varadarajulu S,et al.Systematic review
with meta-analysis: endoscopic retrograde
cholangiopancreatography-based modalities for the diagnosis
of cholangiocarcinoma in primary sclerosing cholangitis[J].
Aliment Pharmacol Ther, 2016, 44(11-12): 1139-1151. DOI:
10.1111/apt.13817.
[22] Lutz HH,Wasmuth HE,Streetz K,et al.Endoscopic ultrasound
as an early diagnostic tool for primary sclerosing cholangitis:a
prospective pilot study[J].Endoscopy,2012,44: 934-939.
[23] Sun B, Moon JH, Cai Q, et al. Review article: Asia-Pacific
consensus recommendations on endoscopic tissue acquisition
for biliary strictures[J].Aliment Pharmacol Ther,2018,48(2):
138-151.
[24] Meister T, Heinzow HS, Woestmeyer C, et al. Intraductal
ultrasound substantiates diagnostics of bile duct strictures of
uncertain etiology[J].World J Gastroenterol, 2013,19:874-881.
[25] Jung YJ,Moon SH,Kim MH.Role of endoscopic procedures in
the diagnosis of IgG4-related pancreatobiliary disease[J].
Chonnam Med J, 2021, 57(1): 44-50. DOI: 10.4068/
cmj.2021.57.1.44.
[26] Han S, Kahaleh M, Sharaiha RZ, et al. Probe-based confocal
laser endomicroscopy in the evaluation of dominant strictures
in patients with primary sclerosing cholangitis: results of a U.
S. multicenter prospective trial[J]. Gastrointest Endosc, 2021,
94(3):569-576.e1. DOI: 10.1016/j.gie.2021.03.027.
[27] Kuraishi Y,Muraki T,Ashihara N,et al.Validity and safety of
endoscopic biliary stenting for biliary stricture associated with
IgG4-related pancreatobiliary disease during steroid therapy
[J].Endosc Int Open,2019,7(11):E1410-E1418. DOI: 10.1055/
a-0966-8494.
[28] Ferreira MTGB,Ribeiro IB,de Moura DTH,et al.Stent versus
balloon dilation for the treatment of dominant strictures in
primary sclerosing cholangitis: A systematic review and
meta-analysis[J]. Clin Endosc, 2021, 54(6): 833-842. DOI:
10.5946/ce.2021.052.
[29] Gotthardt DN,Rudolph G,Klöters-Plachky P,et al.Endoscopic
dilation of dominant stenoses in primary sclerosing
cholangitis: outcome after long-term treatment[J].Gastrointest
Endosc,2010,71(3):527-534. DOI: 10.1016/j.gie.2009.10.041.
[30] Hegade VS, Krawczyk M, Kremer AE, et al. The safety and
efficacy of nasobiliary drainage in the treatment of refractory
cholestatic pruritus: a multicentre European study[J]. Aliment
Pharmacol Ther,2016,43(2):294-302. DOI: 10.1111/apt.13449.
[31] Appleby VJ,Hutchinson JM,Davies MH.Safety and efficacy of
long-term nasobiliary drainage to treat intractable pruritus in
cholestatic liver disease[J].Frontline Gastroenterol,2015,6(4):
252-254.DOI: 10.1136/flgastro-2014-100489.
[32] Jannone G,Stephenne X,Scheers I,et al.Nasobiliary drainage
prior to surgical biliary diversion in progressive familial
intrahepatic cholestasis type II[J].Eur J Pediatr, 2020,179(10):
1547-1552. DOI: 10.1007/s00431-020-03646-z.
[33] Yakar T,Demir M,Gokturk HS,et al.Nasobiliary drainage for
benign recurrent intrahepatic cholestasis in patients refractory
to standard therapy[J].Clin Invest Med, 2016,39(6):27522.
[34] Fasullo M, Patel M, Khanna L, et al. Post-transplant biliary
complications: advances in pathophysiology, diagnosis, and
treatment[J]. BMJ Open Gastroenterol, 2022, 9(1): e000778.
DOI: 10.1136/bmjgast-2021-000778.
[35] Yodice M, Choma J, Tadros M. The expansion of
cholangioscopy: established and investigational uses of
SpyGlass in biliary and pancreatic disorders[J]. Diagnostics
(Basel), 2020,10(3):132. DOI: 10.3390/diagnostics10030132.
[36] Hüsing-Kabar A, Heinzow HS, Schmidt HH, et al.
Single-operator cholangioscopy for biliary complications in
liver transplant recipients[J]. World J Gastroenterol, 2017,
23(22):4064-4071. DOI: 10.3748/wjg.v23.i22.4064.
[37] Yu JF, Zhang DL, Wang YB, et al. Digital single-operator
cholangioscopy for biliary stricture after cadaveric liver
transplantation[J]. World J Gastrointest Oncol, 2022, 14(5):
1037-1049. DOI: 10.4251/wjgo.v14.i5.1037.
[38] Ponsioen CY, Arnelo U, Bergquist A, et al. No superiority of
stents vs balloon dilatation for dominant strictures in patients
with primary sclerosing cholangitis[J].Gastroenterology, 2018,
155(3):752-759.e5. DOI: 10.1053/j.gastro.2018.05.034.
[39] Miyazawa M,Takatori H,Kawaguchi K,et al.Management of
biliary stricture in patients with IgG4-related sclerosing
cholangitis[J].PLoS ONE,2020,15(4):e0232089.DOI: 10.1371/
journal.pone.0232089.